Table 1. Demographic and clinical data of the sample; values of t [82] or x2 and p of the group comparison (M = mean, SD = standard deviation).
| FMS patients N = 52 |
Control group N = 32 |
t[82] / x2 | p | |
|---|---|---|---|---|
| Age (M ± SD) | 51.25 ± 8.67 | 52.94 ± 6.59 | -0.95 | .35 |
| Years of education (M ± SD) | 9.27 ± 3.52 | 10.59 ± 3.64 | -1.65 | .10 |
| BMI (M ± SD) | 28.29 ± 4.49 | 26.49 ± 4.36 | 1.80 | .075 |
| Depression (N, %) | 22 (42.30) | 2 (6.25) | 12.62 | < .0001 |
| Anxiety disorder* (N, %) | 25 (48.08) | 7 (21.88) | 5.77 | .016 |
|
Antidepressant medication (N, %) Anxiolytic medication (N, %) |
27 (51.92) 35 (67.31) |
2 (6.26) 8 (25.00) |
18.28 14.19 |
< .0001 < .0001 |
|
Non-opioid analgesic medication (N, %) Opiate medication (N, %) |
45 (86.5) 23 (44.2) |
8 (25) 1 (31) |
32.22 16.40 |
< .0001 < .0001 |
| State-Trait Anxiety Inventory: State (M ± SD) | 30.92 ± 11.92 | 17.19 ± 9.60 | 5.51 | < .0001 |
| State-Trait Anxiety Inventory: Trait (M ± SD) | 35.29 ± 9.34 | 17.56 ± 10.24 | 8.14 | < .0001 |
| Beck Depression inventory (M ± SD) | 21.90 ± 12.56 | 4.47 ± 5.67 | 7.39 | < .0001 |
| Fatigue Severity Scale (M ± SD) | 50.56 ± 12.35 | 19.88 ± 11.14 | 11.92 | < .0001 |
| Oviedo Quality of Sleep Questionnaire: Insomnia (M ± SD) | 29.73 ± 7.43 | 17.09 ± 7.52 | 7.91 | < .0001 |
| Oviedo Quality of Sleep Questionnaire: Hypersomnia (M ± SD) | 8.67 ± 5.01 | 4.13 ± 1.56 | 4.98 | < .0001 |
| McGill Pain Questionnaire: Sensory Pain (M ± SD) | 35.59 ± 18.39 | 12.38 ± 3.85 | 5.71 | < .0001 |
| McGill Pain Questionnaire: Affective Pain (M ± SD) | 5.92 ± 4.50 | 0.72 ± 0.71 | 5.26 | < .0001 |
|
McGill Pain Questionnaire: Miscellaneous Pain (M ± SD) McGill Pain Questionnaire: Current Pain Intensity (M ± SD) |
9.25 ± 5.90 | 4.14 ± 2.56 | 3.81 | < .0001 |
| 3.31 ± 0.88 | 1.48 ± 0.51 | 8.97 | < .0001 |
* Anxiety disorders comprise panic disorder, generalized anxiety disorder, phobias and adjustment disorder.